FDA NDC Directory · JSON-LD · Markdown
NDC 65862-224 · HUMAN PRESCRIPTION DRUG · SOLUTION, CONCENTRATE
| Labeler / Manufacturer | Aurobindo Pharma Limited |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA078861 |
| Dosage form / route | SOLUTION, CONCENTRATE · ORAL |
| Active ingredients | SERTRALINE HYDROCHLORIDE (20 mg/mL) |
| Marketing started | 20081031 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).